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During kidney development, there is a proliferation, as well as apoptosis of renal cells (18) , and tight regulation of cell growth and apoptosis is essential for formation of normal renal anatomy and cell differentiation. In the mature kidney, recovery from acute renal failure may, at least in part, recapitulate developmental processes. Interruption of renal blood flow leads to ischemia, a major cause of acute renal failure (11) . Ischemia is characterized by ATP depletion and other metabolic disturbances. Restoration of blood flow (reperfusion) is associated with production of reactive oxygen species. Ischemia-reperfusion typically damages renal tubular epithelial cells, but glomerular epithelial cells (GECs, or podocytes) are also injured (32, 33, 41) . Ischemia-reperfusion may lead to apoptosis or necrosis of kidney cells. However, the cells that survive the ischemic insult may undergo dedifferentiation, reentry into the cell cycle, and proliferation to replace the dead cells.
Previously, we demonstrated that expression and activity of the Ste20-like kinase SLK (a group V GCK) were increased in rat fetal kidney homogenates compared with adult control kidneys (8) . Furthermore, we showed that ischemia-reperfusion injury enhanced SLK expression and activity in adult rat kidneys. SLK was localized mainly in the cytoplasm of tubular epithelial cells in fetal and adult kidneys, and in addition there was expression in developing and mature podocytes. Thus SLK is a renal epithelial protein kinase, whose expression and activity are increased during development, as well as recovery from acute renal failure, where injured tubular epithelial cells may regenerate by recapitulating developmental processes (11) . The expression of SLK in GECs suggests a possible role in glomerulogenesis or glomerular injury.
We and others have characterized several functional and regulatory aspects of SLK. In cultured cells, chemical anoxia and reexposure to glucose (anoxia/recovery; A/R) recapitulates the ATP depletion and production of reactive oxygen species seen during ischemia-reperfusion in vivo. Exposure of cultured kidney epithelial cells to A/R stimulated SLK activity (8) . Incubation of cultured kidney epithelial cells with serum, a source of growth factors, also increased SLK activity (8) . Overexpression of SLK in renal epithelial cells under normal culture conditions attenuated increases in cell number due to apoptosis; in the setting of A/R, forced SLK expression exacerbated cell death (8, 14) . In other cell lines, transient overexpression of SLK also induced apoptosis (35, 36) . Alternatively, another study has also shown a requirement for SLK for progression through the cell cycle (27) . In regard to regulatory mechanisms of SLK activation, we have shown that the SLK 3Ј-untranslated region may interact with kidney RNA-binding proteins to regulate expression of SLK mRNA (7) . At the protein level, SLK may dimerize via the C-terminal domain, and dimerization may enhance SLK activity (14) . Phosphorylation or dephosphorylation of SLK was associated with changes in SLK activity in some, but not all studies (5, 12, 14, 29, 35, 36) . Several studies have reported that downstream signaling by SLK involves mitogen-activated protein kinase pathways. We demonstrated that in kidney epithelial cells, SLK induced phosphorylation of apoptosis signal-regulating kinase-1 (ASK1) and increased ASK1 activity, indicating that ASK1 is a substrate of SLK (14) . Moreover, it was shown that SLK stimulated phosphorylation of p38 mitogen-activated protein kinase (p38) via ASK1 (14) and that SLK can lead to the activation of JNK (35, 36) . In kidney epithelial cells, overexpression of SLK enhanced A/R-induced apoptosis, release of cytochrome c, as well as activities of caspases-8 and -9, and apoptosis was reduced significantly with p38 and caspase-9 inhibitors (14) .
In this study, we address the role of p53 as a potential proapoptotic effector of SLK. p53, known as the "guardian of the genome," is a master regulator of cell proliferation and death (1, 23, 28) . The amount or activity of p53 may increase in response to growth factor withdrawal or cell injury via several complex mechanisms that include increased translation, decreased degradation, and increased half-life, phosphorylation, and acetylation (22, 26) . Activated p53 can block steps in the progression of the cell cycle or can induce apoptosis via transcriptional or transcription-independent mechanisms (28, 39) . We show that SLK stimulates p53 transactivational activity in association with phosphorylation of p53. The amount of apoptosis after in vitro ischemia-reperfusion injury and SLK overexpression was attenuated significantly by a p53 transactivation inhibitor.
MATERIALS AND METHODS

Materials.
Tissue culture and molecular biology reagents were obtained from Invitrogen Life Technologies (Burlington, ON) and Wisent (St. Bruno, QC). Electrophoresis and immunoblotting reagents were from Jackson ImmunoResearch (West Grove, PA), Pall (Pensacola, FL), and GE Healthcare (Baie d'Urfé, Quebec). Pifithrin-␣, puromycin aminonucleoside, propidium iodide, SB203580, and mouse anti-FLAG antibody were purchased from Sigma-Aldrich Canada (Mississauga, ON). Bisbenzimide H33342 fluorochrome and SP600125 were obtained from Calbiochem (San Diego, CA). The mouse anti-hemaglutinin (HA) antigen epitope tag was from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-phospho-JNK, rabbit anti-phospho-p38, rabbit anti-p53, and all p53 phospho-specific antibodies were from Cell Signaling Technology (Danvers, MA). The Dual Luciferase Reporter Assay System and the plasmid pRL were purchased from Promega (Madison, WI). HA-SLK, HA-SLK 1-373, myc-SLK K63R, ASK1, constitutively active MEKK1, and constitutively active transforming growth factor-␤ activated kinase-1 (TAK1) cDNAs were described previously (3, 14, 38) . Plasmids p53 wild-type (wt), pp53-TA-luc (p53-luc), and pTA-luc were from Clontech (Mountain View, CA). Plasmid p53mt135, which encodes a dominant negative p53 mutant, was from Stratagene (La Jolla, CA). cDNA encoding the dominant negative p53 mutant FLAG-p53 miniprotein (p53mini) (24) was kindly provided by Dr. Joseph Avruch (Harvard University, Boston, MA). p53 S33A, S315A, and S33A/S315A cDNAs (44) were kindly supplied by Dr. Z. Xiao (Boston University, Boston, MA). Dominant negative JNK (FLAG-JNKapf) and p38 (FLAG-p38apf) cDNAs (3) were gifts from Dr. R. Davis (University of Massachusetts, Worcester, MA). Constitutively active mitogen-activated protein kinase kinase-3 (MKK3) cDNA was from Stratagene.
Cell culture and transfection. COS-1 cells and GECs were employed for studies involving transient transfection. Madin-Darby canine kidney (MDCK) cells (a kidney tubule epithelial cell line) stably transfected with HA-SLK were characterized previously (14) . MDCK cells and COS cells were cultured in DMEM-10% fetal bovine serum.
GEC culture and characterization has been published previously (6, 8, 14) . GECs were cultured in K1 medium, and studies were done with cells between passages 8 and 60. Transient transfection was performed using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. In preliminary studies, based on transfection of green fluorescent protein, the transfection efficiency of COS cells was Ͼ60%, while transfection efficiency in GECs was ϳ10%.
Immunoblotting. Generally, cells were plated into 35-mm culture dishes and were transfected with 1 g of plasmid DNA. Methods for harvesting cells and immunoblotting were described previously (14) . For immunoblotting, equal amounts of proteins were loaded into each lane of a gel. Quantification of immunoblots was performed by densitometry. Blots were scanned, specific bands of interest were selected, and the density of the bands was measured using National Institutes of Health ImageJ software (14) . Preliminary studies demonstrated that there was a linear relationship between densitometric measurements and the amounts of protein loaded onto gels.
p53 dual luciferase reporter assay. COS cells or GECs were plated into 24-well tissue culture dishes. Cells were transiently transfected with the firefly luciferase reporter plasmid that contains a p53 cisacting enhancer element, p53-luc (10 ng in COS cells, 100 ng in GECs), and the Renilla luciferase reporter plasmid pRL cDNAs (1 ng in COS cells, 10 ng in GECs), plus other cDNAs of interest (100 -200 ng). The Renilla luciferase reporter plasmid was included in all transfections to normalize for transfection efficiency. Cells were harvested after 48 h according to the instructions provided with the Dual Luciferase Reporter Assay System. Firefly and Renilla luciferase reporter luminescences were measured sequentially in a Lumat LB 9507 luminometer. Luciferase activity is presented in arbitrary units, calculated separately for each experiment (the absolute units are not comparable among the various experiments).
Measurement of apoptosis. Apoptosis was quantified by Hoechst H33342 and propidium iodide staining, as described previously (8, 14) . In this assay, nuclei of apoptotic cells, which show chromatin condensation and fragmentation, stain brightly with H33342 and are stained negatively with propidium iodide. Propidium iodide-positive cells are generally "late apoptotic," as apoptotic cells in culture are not phagocytosed and may proceed to necrosis. Analysis was performed using the University of Texas Science Center at San Antonio Image Tool program.
Statistics. Data are presented as means Ϯ SE. The t-statistic was used to determine significant differences between two groups. Oneway ANOVA was used to determine significant differences among groups. Where significant differences were found, individual comparisons were made between groups using the t-statistic and adjusting the critical value according to the Bonferroni method.
RESULTS
SLK stimulates p53 reporter activity.
In previous studies, we showed that SLK expression and activity increase in the developing kidney and in renal ischemia-reperfusion injury. Overexpression of SLK in cultured cells (which we have used to model the increased expression observed in the in vivo circumstances) resulted in a modest proapoptotic effect, and markedly exacerbated apoptosis following in vitro ischemiareperfusion injury (A/R) in renal epithelial cells (8, 14) . In the present study, we address the role of the tumor suppressor and proapoptotic p53 as a potential mediator of the effects of SLK. First, we proceeded to determine whether SLK could stimulate transactivation of p53. We established a p53 reporter assay, which employs a luciferase reporter plasmid that contains a p53 cis-acting enhancer element, and we used the assay to measure p53 transactivational activity in COS cells, which express relatively high basal p53 protein, and in GECs, where basal p53 protein expression in low (Fig. 1A) . By analogy to protein expression, basal p53 luciferase activity was more than fourfold greater in COS cells compared with GECs (Fig. 1B) . In COS cells, transient transfection of SLK increased p53 reporter activity more than twofold (Fig. 1C) . Expression of endogenous and ectopic SLK in COS cells was presented previously (8) . p53 reporter activity was abolished almost completely in control and SLK-transfected COS cells that had been cotransfected with two distinct p53 dominant negative mutants, p53mini and p53mt135 (data not shown). Compared with COS cells, transfection efficiency in GECs is low. Nevertheless, transient transfection of SLK in GECs stimulated basal p53 reporter activity ϳ1.4-fold (Fig. 1C) . Basal p53 reporter activity was increased by transient transfection of p53wt cDNA (Fig. 1D ) and was inhibited almost completely after transfection of the two p53 dominant negative mutants (data not shown). As expected, treatment of GECs with the p53 inhibitor pifithrin-␣ (17) abolished p53 reporter activity (Fig.  1D ), although it has been suggested that pifithrin-␣ can also inhibit luciferase activity directly (34) . Finally, transient cotransfection of GECs with SLK plus p53 ( Fig. 1E ) increased p53 reporter activity compared with p53 alone (Fig. 1F) .
Effect of A/R and SLK on p53 reporter activity. p53 reporter activity tended to increase after exposure of COS cells to A/R (4-h recovery) and tended to increase further when SLK-transfected COS cells were subjected to A/R, although the A/R-induced changes were not statistically significant ( Fig. 2A) . While signaling by SLK may be related, at least in part, to increased expression, we also examined whether endogenous SLK may affect the p53 reporter, by employing a kinase inactive SLK mutant (SLK K63R), which acts as a dominant inhibitor (14, 35, 36) . Transfection of SLK K63R reduced p53 reporter activity in untreated COS cells, or in COS cells subjected to A/R (Fig. 2B ). In addition, we examined whether A/R affected the level of p53 protein expression in COS cells. After 1 h of recovery, there was an almost twofold increase in p53 expression, whereas after 4 h, expression of p53 in cells subjected to A/R was comparable to control (Fig. 2, C and D) . In GECs, A/R stimulated p53 reporter activity, and the reporter activity was further enhanced by transient transfection of SLK (Fig.  2E ). SLK K63R did not inhibit p53 reporter activity significantly in GECs (Fig. 2E) . Together, these results indicate that overexpression of SLK enhances activation of p53 by A/R in GECs, while the effect of A/R in COS cells was not significant. Conversely, endogenous SLK may, in part, mediate activation of the p53 reporter, at least in COS cells. The reason for the discrepancy between COS cells and GECs may be related to efficiency of transfection and expression of the K63R plasmids in the two cell lines. Alternatively, the effects of endogenous SLK and A/R signaling may be distinct in the two cell lines.
Puromycin aminonucleoside is a compound that is selectively injurious to GECs in vivo and in culture; in vivo, puromycin aminonucleoside induces proteinuria and focal segmental glomerulosclerosis in rats. In the next series of experiments, we examined the effects of puromycin aminonucleoside and SLK on p53 reporter activity. By analogy to A/R, puromycin aminonucleoside stimulated p53 reporter activity, and this activity was further enhanced by transient transfection of SLK (Fig. 3A) . The stimulatory effect of puromycin aminonucleoside on p53 reporter activity was attenuated significantly by SLK K63R (Fig. 3B) . Therefore, overexpression of SLK enhances activation of the p53 reporter by puromycin aminonucleoside, and endogenous SLK may, in part, mediate puromycin aminonucleoside-induced p53 transactivation. For comparison, we also studied the activation of the p53 reporter by UV radiation, a well-known potent activator of p53. As expected, exposure of GECs to UV light stimulated p53 reporter activity (Fig. 3C) , and the magnitude of p53 reporter activation was comparable to the other stimuli. . B: basal p53 activity in COS cells and GECs was measured after transient transfection of a firefly luciferase reporter plasmid that contains a p53 cis-acting enhancer element (p53-luc). COS cells contain significantly greater p53 activity compared with GECs (*P Ͻ 0.0001 COS vs.. GECs, 13 experiments). There is almost no activity after transfection of pTA-luc, a control luciferase plasmid that is missing the p53 response element. Luciferase activity is presented in arbitrary units calculated separately in each panel (the units are not comparable among the various panels). C: COS cells or GECs were transiently transfected with vector or HA-SLK. SLK stimulated p53 reporter activity (measured after 48 h; COS: *P Ͻ 0.04 SLK vs.. vector, 9 experiments; GECs: *P Ͻ 0.0001 SLK vs.. vector, 19 experiments). D: GECs were transiently transfected with vector alone or p53 wild-type and were incubated with or without pifithrin-␣ (Pif; 10 M). p53 enhanced, and pifithrin-␣ inhibited, p53 reporter activity (*P Ͻ 0.005 p53wt vs.. vector, **P Ͻ 0.0001 vs.. p53wt, 3 experiments). E: GECs were transiently transfected with vector alone (Ϫ), hemagglutinin (HA)-SLK, and/or p53wt. Lysates were immunoblotted with anti-HA antibody (top) or anti-p53 antibody (bottom). F: GECs were transiently transfected with vector alone, p53wt, HA-SLK, or p53wtϩSLK. SLK stimulated p53 reporter activity (*P Ͻ 0.0001 p53 vs.. vector, **P Ͻ 0.0001 p53ϩSLK vs.. vector, and P Ͻ 0.01 p53ϩSLK vs. p53 alone, 5-13 experiments).
SLK induces phosphorylation of p53. Based on the results of the above studies, we hypothesized that SLK may regulate p53 activity via phosphorylation. In the first series of experiments, we examined the effect of SLK on p53 phosphorylation by immunoblotting, using various phospho-p53-specific antibodies (Fig. 4A) . The effect of UV radiation was studied for comparison. In COS cells, basal p53 phosphorylation was prominent on a number of serine residues, notably serine 9 , serine 15 , serine 33 , and serine 315 . Transfection of SLK increased phosphorylation consistently of serine 33 and serine 315 ( Fig. 4A ; densitometric quantification: 148 Ϯ 23% of baseline, P Ͻ 0.025, and 193 Ϯ 65% of baseline, P Ͻ 0.001, respectively; 3 experiments). Transfection of SLK had no effect on phosphorylation of serines 6, 9, 15, 20, and 37. SLK also induced phosphorylation of serine 46 and serine
392
, but these results were not observed consistently in every experiment, and will require confirmation in further studies. SLK did not induce phosphorylation of threonine 81 . UV light induced p53 phosphorylation at multiple sites. Transfection of SLK or UV radiation did not affect expression of p53. SLK induces phosphorylation of ASK1 and increases ASK1 activity, indicating that ASK1 is a substrate of SLK (14) . By analogy to SLK, transfection of ASK1 induced p53 phosphorylation of serine 33 and serine 315 ( Fig. 4B ; densitometric quantification: 123 Ϯ 7% of baseline, P Ͻ 0.001, and 179 Ϯ 40% of baseline, P Ͻ 0.05, respectively; 3 experiments).
Phosphorylation of p53 on serine 33 and serine 315 was then confirmed in GECs. The cells were transiently transfected with p53 and SLK, and for comparison, cells were subjected to UV radiation. In GECs, basal phosphorylation of these serines was relatively low. Similar to COS cells, SLK induced p53 phosphorylation consistently on serine 33 ( Fig. 5 , A and D) and serine 315 (Fig. 5, B and D) . In regard to threonine 81 , basal phosphorylation of this residue was noted in GECs, although as in COS cells, transfection of SLK did not affect the level of phosphorylation (Fig. 5C ). We also examined the effects of ASK1 on p53 phosphorylation in GECs. Similar to SLK, transfection of ASK1 induced p53 phosphorylation on serine 33 and serine 315 (Fig. 5, A and B) . In addition, we could not detect phosphorylation of p53 on threonine 81 following transfection of ASK1 (not shown). Transfection of SLK and ASK1 did not affect expression of ectopic p53 (Fig. 5, A and B) .
Stimulation of p53 reporter activity by SLK is dependent on serine 33 and serine 315 phosphorylation. The studies described above demonstrated that SLK can induce an increase in p53 transactivation and phosphorylation of p53 on serine 33 and serine 315 . To determine whether these phosphorylations are functionally important, we examined transactivation of three p53 mutants, including S33A, S315A, and the double mutant (S33AϩS315A). For these studies, we employed GECs, as these cells have low endogenous p53 expression and reporter Fig. 3 . Puromycin aminonucleoside (PA), UV radiation, and SLK stimulate p53 reporter activity. A: GECs were transiently transfected with HA-SLK or vector alone and were untreated or treated with (PA; 50 g/ml, 24 h). p53 reporter activity increased after PA and was further enhanced by SLK transfection (*P Ͻ 0.005 PAϩvector vs. vector, **P Ͻ 0.001 SLKϩPA vs. vectorϩPA, 4 experiments). B: GECs were transiently transfected with SLK K63R or vector alone and were untreated or treated with PA. SLK K63R attenuated PA-stimulated p53 reporter activity (*P Ͻ 0.0001 PAϩvector vs. vector, **P Ͻ 0.002 K63RϩPA vs. vectorϩPA and P Ͻ 0.02 K63RϩPA vs. K63R, 6 experiments). C: GECs were transiently transfected with p53 or vector alone and were untreated or exposed to UV light for 2 min. p53 reporter activity was assayed after 90 min. UV stimulated p53 reporter activity (*P Ͻ 0.001 p53 vs. vector, **P Ͻ 0.001 vectorϩUV vs. vector, ϩ P Ͻ 0.003 p53ϩUV vs. p53, 4 experiments). A: COS cells were transiently transfected with HA-SLK or vector alone, and were untreated or subjected to anoxia (40 min) and recovery (4 h). p53 reporter activity was increased significantly after SLK transfection and A/RϩSLK (*P Ͻ 0.04 SLK vs. vector, **P Ͻ 0.005 SLKϩA/R vs. vector, 6 experiments). B: COS cells were transiently transfected with dominant negative SLK (SLK K63R) or vector alone and were untreated or subjected to A/R. p53 reporter activity was inhibited significantly by SLK K63R (*P Ͻ 0.005, **P Ͻ 0.01 SLK K63R vs. vector, 6 experiments). C and D: A/R increases p53 expression. p53 levels were measured by immunoblotting with anti-p53 antibody in COS cells that were untreated (control), or subjected to anoxia followed by recovery of 1, 4, and 24 h. A representative immunoblot showing duplicate samples is presented in C and quantification of 4 experiments in D (*P Ͻ 0.0001 A/R vs. Ctrl). An actin immunoblot is presented as a loading control (C). E: GECs were transiently transfected with SLK, SLK K63R, or vector alone and were untreated or subjected to A/R. p53 reporter activity increased after SLK transfection, A/R, and A/RϩSLK transfection. [*P Ͻ 0.002 SLK vs. vector (Untr), **P Ͻ 0.025 A/R vs. Untr (vector), ϩ P Ͻ 0.0001 A/R vs. Untr (SLK) and P Ͻ 0.0001 SLK vs. vector (A/R), 4 experiments]. activity ( Fig. 1, A and B) . Wild-type p53 or mutants (Fig. 6A) were transiently expressed in GECs with SLK (or vector). Stimulated p53 activity of the S33A mutant was comparable to p53 wild-type (Fig. 6B) . The S315A mutant showed a partial reduction in stimulated p53 activity, while the double mutant showed almost no stimulated activity (Fig. 6B) . In contrast, SLK was able to activate an unrelated p53 mutant (S15G; Fig.  6C ). Together, the results indicate that the principal effect of SLK on p53 activation is via phosphorylation of serine 315 but that serine 33 is required for full activation. Role of JNK and p38 pathways in SLK-induced p53 reporter activation. In certain cell lines, SLK is a component of the mitogen-activated protein kinase pathways that are activated by stress (14, 35, 36) . We confirmed that SLK can signal via JNK and p38 pathways in GECs (see below), and we examined the functional role of JNK and p38 in SLK-mediated p53 activation. By analogy to earlier experiments, SLK stimulated p53 reporter activity significantly, but in the presence of dominant negative JNK (JNKapf) or p38 (p38apf), the stimulated p53 reporter activity was attenuated, and the change was not significant (Fig. 7, A and B) . In keeping with these results, incubation of GECs with the JNK-directed inhibitor SP600125 (4) reduced stimulated p53 reporter activity (Fig. 7C) . However, the p38-directed inhibitor SB203580 (10, 42) did not reduce SLK-induced stimulation of p53 reporter activity significantly (Fig. 7D) .
Activation of p53 by other stress protein kinases.
In these experiments, we examined the effects of other members of the stress kinase pathways on p53 activation. ASK1 and TAK1 are protein kinases upstream of JNK and p38, MEKK1 is reported to be a kinase upstream of JNK, while MKK3 is immediately upstream of p38 (20) . GECs were transiently transfected with vector alone, p53wt, protein kinase, or p53wt plus protein kinase. As expected, ASK1, which lies downstream of SLK (14) stimulated p53 reporter activity in the presence of ectopic p53 (Fig. 8A) . Similarly, constitutively active MEKK1 and constitutively active TAK1 stimulated p53 reporter activity (Fig. 8, B and C) . Surprisingly, constitutively active MKK3 inhibited p53 reporter activity (Fig. 8D) . In the presence of ectopic p53, MKK3 reduced p53 reporter activity by ϳ80%; however, after incubation with SB203580, the inhibitory effect of MKK3 was largely abolished (Fig. 8D) .
We then verified whether transient transfection of SLK and the other stress kinases activated the JNK and/or p38 pathways in GECs by monitoring activation-specific phosphorylation of JNK and p38 (Fig. 9 ). In keeping with previous results in COS cells (14) , transfection of SLK induced p38 phosphorylation in GECs. In addition, SLK induced phosphorylation of the 46-kDa, and to a lesser extent, the 54-kDa JNK isoform. A similar pattern of phosphorylation was induced by ASK1 and TAK1, although the phosphorylation of p38 by TAK1 was less consistent. Constitutively active MEKK1 induced phosphorylation of both JNK isoforms (46 and 54 kDa) as well as p38. Constitutively active MKK3 induced phosphorylation of only p38. As expected, GECs that were subjected to UV radiation showed intense phosphorylation of both JNK isoforms and p38.
SLK enhances the effect of A/R on apoptosis via p53.
In previous studies, we demonstrated that overexpression of SLK markedly exacerbated apoptosis (monitored by Hoechst staining), release of lactate dehydrogenase, release of cytochrome c, and activities of caspases-8 and -9 following in vitro ischemiareperfusion injury (A/R) in GECs and/or MDCK cells (8, 14) . In the following experiments, we employed MDCK cells, which show a low level of p53 expression, comparable to GECs (Fig. 1A) . MDCK cells were exposed to A/R in the presence or absence of the p53 inhibitor pifithrin-␣. Apoptosis was enhanced significantly after A/R, and this increase was attenuated by pifithrin-␣ (Fig. 10A) . A similar result was observed in GECs (not shown). In keeping with previous results, stable overexpression of SLK in MDCK cells enhanced the proapoptotic effect of A/R. Furthermore, this increase in apoptosis was also blocked by pifithrin-␣ (Fig. 10A) .
We also verified the functional effects of SLK in COS cells. After transient transfection of SLK in COS cells, the number of apoptotic cells (measured by Hoechst staining) increased to 3.35 Ϯ 0.47 compared with 1.76 Ϯ 0.35% in control (after 48 h of culture; P Ͻ 0.015; 5 experiments). We then examined the effect of endogenous SLK on A/R-induced injury. In COS cells, apoptosis plus late apoptosis following A/R were attenuated significantly after expression of dominant negative SLK (SLK K63R) (Fig. 10B) . Unlike the MDCK cells, where late apoptotic cells were a minority, in COS cells, the late apoptotic cells were more numerous, compared with the early apoptotic cells. Since the COS cells were transiently transfected with cDNAs, it is possible that the transfection reagents plus the A/R injury rendered the membranes more susceptible to loss of integrity. Together, these results indicate that overexpression of SLK can exacerbate A/R-induced apoptosis, and endogenous SLK may partially mediate A/R-induced apoptosis; moreover, the apoptotic pathway appears to involve p53, at least in part.
DISCUSSION
Previously, we demonstrated that SLK expression and activity increased following renal ischemia-reperfusion injury in vivo and that overexpression of SLK in cultured renal epithelial cells (employed to model the increased in vivo expression) exacerbated apoptosis induced by A/R (8, 14) . We and others have shown that in certain cell lines, SLK can signal via stress kinase pathways (14, 35, 36) . The present study addressed the role of p53 as a potential mediator of the actions of SLK. To examine whether SLK could stimulate p53 transactivation, studies were carried in COS cells, which express relatively high basal p53 protein and activity (with no apparent proapoptotic effect), as well as in GECs, where basal p53 protein expression and activity are low, with and without expression of ectopic p53 (Fig. 1) . The latter cell line is in keeping with many resting cells, where p53 protein concentrations are low, as p53 is ubiquitinated and degraded (22, 26) . Overexpression of SLK by transfection increased p53 reporter activity in COS cells and in GECs (Fig. 1) . p53 reporter activity increased after exposure of GECs to A/R and increased further when SLK-transfected GECs were subjected to A/R. In Fig. 6 . Stimulation of p53 reporter activity by SLK: role of p53 serine 33 and serine 315 phosphorylation. A and B: GECs were transiently transfected with vector alone, p53 wild-type (WT), and the p53 S33A, S315A, or S33AϩS315A mutants. HA-SLK was included in some transfections. A: representative anti-p53 antibody immunoblot shows expression of ectopic p53. Note that migration of p53 mutants is slightly retarded compared with WT, since the mutants contain a HA-tag, whereas the WT does not. Endogenous p53 is not detected at this exposure (NS; nonspecific band). B: compared with vector, p53 reporter activity was enhanced by transfection of HA-SLK in the presence of p53wt and p53 S33A (*P Ͻ 0.02, **P Ͻ 0.03, 8 experiments). Stimulated p53 activity was reduced in the presence of p53 S315A, and markedly by the double mutant. C: GECs were transiently transfected with vector alone, p53wt, or p53 S15G with or without HA-SLK. Compared with vector, p53 reporter activity was enhanced by HA-SLK transfection in the presence of p53wt and p53 S15G (*P Ͻ 0.02, **P Ͻ 0.05, 6 experiments). COS cells, these changes did not reach statistical significance, perhaps be due to a small magnitude of the effect (Fig. 2) . Expression of dominant negative SLK reduced p53 reporter activity in untreated COS cells, and in COS cells subjected to A/R, while this effect in GEC was slight and not statistically significant (Fig. 2) . This discrepancy between COS cells and GECs may be related to efficiency of transfection and expression of the SLK K63R cDNA in the two cell lines. Alternatively, there may be certain differences in signaling by ectopic or endogenous SLK, and by A/R between COS cells and GECs, or cell-specific differences in p53 function. p53 protein expression in COS cells was increased by A/R, although the change was small and was not sustained beyond 1 h of recovery (Fig. 2) . By analogy, small increases in p53 protein expression have been reported in other renal epithelial cell lines after A/R (16).
The GEC toxin puromycin aminonucleoside was reported to upregulate p53 and induce apoptosis in cultured GECs via a pathway involving p53 (25, 40) . We observed that in GECs, puromycin aminonucleoside stimulated p53 reporter activity, and this activity was further enhanced by transient transfection of SLK (Fig. 3) . In contrast, the stimulatory effect of puromycin aminonucleoside on p53 reporter activity was attenuated significantly by dominant negative SLK (Fig. 3) . Thus overexpression of SLK enhanced activation of p53 by puromycin aminonucleoside, and endogenous SLK may, in part, mediate the puromycin aminonucleoside-induced activation of p53. The mechanisms by which A/R and puromycin aminonucleoside may increase SLK activity may include mRNA stabilization, increased homodimerization or phosphorylation, and others (7, 8, 14) , but a definition of these mechanisms will require further study. By analogy, it has been demonstrated that other GCKs may be activated by stress, but the mechanisms so far remain obscure (30, 31) .
To determine whether SLK stimulates p53 transactivation via phosphorylation, we initially screened multiple p53 phosphorylation sites in COS cells, using p53 phospho-specific antibodies. Certain serine and threonine residues were phosphorylated under basal conditions. SLK induced phosphorylation consistently on serine 33 and serine 315 , but we did not detect phosphorylation on serines 6, 9, 15, 20, and 37, and threonine 81 (Fig. 4) . Phosphorylation of p53 on serine 33 and serine 315 was confirmed in GECs (Fig. 5) . By analogy to SLK, transfection of ASK1 (a substrate of SLK) (14) induced p53 phosphorylation on serine 33 and serine 315 (Fig. 4 and 5) . We GECs were transiently transfected with protein kinases as indicated, and phospho-JNK (pJNK; 46-and 54-kDa isoforms) and phospho-p38 (pp38) were assessed after 48 h by immunoblotting. For comparison, GECs were subjected to UV radiation (see legend to Fig. 3) . SLK induced phosphorylation of JNK and p38. A similar pattern of phosphorylation was induced by ASK1, TAK1, and MEKK1. Constitutively active MKK3 induced phosphorylation of only p38. UV induced potent phosphorylation of p38 and both JNK isoforms. also examined if SLK or ASK1 could directly phosphorylate p53 serine 33 or serine 315 using an in vitro immune complex kinase assay (15), but we did not detect any phosphorylation (results not shown). Therefore, the p53 phosphorylation by SLK or ASK1 is most likely mediated via intermediary protein kinases. In addition, we could not detect phosphorylation of p53 on threonine 81 following transfection of SLK or ASK1, although this residue appeared to be phosphorylated under basal conditions. By monitoring transactivation of three p53 mutants, including S33A, S315A, and the S33AϩS315A double mutant, we demonstrated that serine 33 and serine 315 phosphorylations are functionally important targets of SLK. Compared with p53wt, the S315A mutant showed a partial reduction in SLK-stimulated activity, while the double mutant showed almost no stimulated activity (Fig. 6) . The results imply that the principal effect of SLK on p53 activation appears to be via phosphorylation of serine 315 , but that serine 33 is required for full activation.
A subset of GCKs are members of the mitogen-activated protein kinase pathways that are activated by stress (9) . We and others have demonstrated that in certain cell lines, SLK is a component of the stress kinase pathways (14, 35, 36) . The potential role of intermediary stress kinases JNK and p38 in the activation of p53 was examined by monitoring SLK-induced changes in p53 reporter activity in the presence of JNK and p38 inhibitors. After transfection of dominant negative JNK and p38 mutant cDNAs (JNKapf and p38apf), and after addition of the JNK-directed inhibitor SP600125, SLK-stimulated p53 reporter activity was attenuated (Fig. 7) . The p38-directed inhibitor SB203580 did not, however, reduce SLK-stimulation of p53 reporter activity significantly. Compared with p38apf, the incomplete effect of SB203580 may reflect the inability of this compound to block all p38 isoforms. Alternatively, the effect of p38 on p53 activation may be minor.
The MEKK family includes ASK1, MEKK1, and TAK1 (20) . MEKK1 is regarded as a relatively selective activator of the JNK pathway, whereas TAK1 and ASK1 can activate both JNK and p38 pathways (20) . MKK3 is a kinase immediately upstream of p38. In addition, ASK1 is a substrate of SLK (14) , while MEKK1 is a substrate of group I GCKs (20) . In the present study, we employed ASK1, and constitutively active MEKK1, MKK3, and TAK1, to compare the activation of p53 by these stress kinases with SLK. Transient transfection of GECs with ASK1, MEKK1, and TAK1 stimulated p53 reporter activity, but unexpectedly, constitutively active MKK3 inhibited p53 reporter activity (Fig. 8) . Under similar experimental conditions, transfection of SLK in GECs induced activation of p38 (as reflected by p38 phosphorylation), as well as phosphorylation of the 46-kDa, and to a lesser extent, the 54-kDa JNK isoform (Fig. 9) . A similar pattern of JNK and p38 phosphorylation was induced by ASK1 and TAK1, although the phosphorylation of p38 by TAK1 was less consistent. As expected, MEKK1 induced phosphorylation of 46-and 54-kDa JNK isoforms (20) , but under our experimental conditions p38 was also activated (Fig. 9) . As predicted, MKK3 induced phosphorylation of only p38 (20) .
Together, the results show a complex pattern of p53 activation by SLK. It can be concluded that SLK, as well as other MEKK family members, can activate p53 via JNK. We cannot exclude a supportive role for p38 in the context of JNK activation, since SLK and the various kinases of the MEKK family activated JNK together with p38. However, activation of p38 alone (i.e., as reflected by MKK3 transfection) inhibited p53 activity. Therefore, if p38 is activated together with JNK, the role of the p38 pathway in the regulation of p53 activity may be minor. Furthermore, inhibition of the p38 pathway did not result in hyperactivation of p53 (Fig. 7) , suggesting that activation of p38 by SLK (Fig. 9) did not contribute to downregulation of p53 activity. Possibly, MKK3 transfection affected other endogenous negative modulators of p53 activity. Inhibition of the JNK pathway (Fig. 7) may not block stimulated p53 activity entirely, suggesting that other intermediary kinases may also be involved downstream of SLK. Protein kinases previously reported to induce phosphorylation of p53 serine 33 include p38, as well as glycogen synthase kinase-3␤ and cyclin-dependent kinase-7 (2, 22, 26) . JNK was previously implicated in the phosphorylation of serine 20 and threonine 81 (2, 22, 26 ), but we did not detect phosphorylation of these sites by SLK. Kinases previously reported to induce phosphorylation of serine 315 include aurora kinase A, cyclin-dependent kinase-7, and glycogen synthase kinase-3␤ (2, 26) . Both aurora kinase A and cyclin-dependent kinase-7 may be involved in progression through the G2 and mitosis phases of the cell cycle (13, 21) , and it has been shown that inhibition of SLK may also impair progression of cells through G2 and mitosis (27) . Although such observations may be coincidental, it is possible that SLK might interact with at least one of these kinases, leading to p53 serine 315 phosphorylation. Delineation of the kinase(s) involved in serine phosphorylation by SLK will require further study. Interestingly, phosphorylation of p53 on serine 33 , serine 315 , and threonine 81 contributes to efficient interaction with Pin1, which, in turn, leads to a conformational change in p53 that enhances its activity (43, 44) . As the two serine phosphorylations were induced by SLK, and some threonine phosphorylation was present constitutively, involvement of Pin1 is a potential mechanism for the observed increase in p53 activity.
In keeping with other studies (16, 37) , we have demonstrated that A/R-induced apoptosis can be reduced by the p53 transactivation inhibitor pifithrin-␣ (Fig. 10) . A significant exacerbation of apoptosis induced by SLK overexpression became evident when GECs or MDCK cells were subjected to A/R (Fig. 10) (8, 14) . Conversely, endogenous SLK may also contribute to A/R-induced apoptosis, e.g., in COS cells (Fig.  10) . Furthermore, the amount of apoptosis after SLK overexpression and A/R was attenuated significantly by pifithrin-␣, implying that the proapoptotic effect of SLK is mediated, at least in part, via p53 (Fig. 10) . Activation of p53 may lead to cell cycle arrest and/or apoptosis. The former depends on transcriptional induction of p21 and other genes (22, 26) . Transcription of multiple p53-dependent genes may be involved in the induction of apoptosis, including bcl-2 family members puma, noxa, and others. Besides the ability to transactivate proapoptotic target genes, p53 may induce apoptosis posttranslationally, by activating Bax or Bak (26, 28, 39) , although the latter pathway may be relatively minor. It should be noted that stable overexpression of SLK in GECs and MDCK cells (8) , or transient transfection in COS cells (RESULTS) had a modest proapoptotic effect, which became evident after 2-3 days of culture, and was tolerated by the cells (8) . Cell cycle analysis in MDCK cells showed that in the presence of SLK overexpression, progression through the cell cycle was re-duced, while the appearance of apoptotic cells increased (14) . There were no apparent changes in p21 expression (14) . While we have demonstrated using a reporter system that SLK induces p53 transactivation, delineation of p53 targets in renal epithelial cells will require further study. SLK induced changes in p53 phosphorylation and activity directly; however, A/R may potentially also induce changes in these parameters, and this possibility will require additional investigation. Further studies will also be required to define the functional roles of SLK and p53 in vivo. A better understanding of SLK signaling in the kidney may eventually lead to new therapeutic strategies for renal ischemia-reperfusion injury. 
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